Shares of ValiRx plc (LON:VAL – Get Free Report) crossed above its fifty day moving average during trading on Wednesday. The stock has a fifty day moving average of GBX 0.14 and traded as high as GBX 0.15. ValiRx shares last traded at GBX 0.15, with a volume of 20,712,516 shares.
ValiRx Price Performance
The business has a 50 day moving average of GBX 0.14 and a 200 day moving average of GBX 0.22. The firm has a market capitalization of £2.51 million, a price-to-earnings ratio of -0.46 and a beta of 0.59.
ValiRx (LON:VAL – Get Free Report) last announced its quarterly earnings results on Tuesday, September 15th. The company reported GBX (0.09) earnings per share (EPS) for the quarter. ValiRx had a negative net margin of 6,548.06% and a negative return on equity of 71.49%. On average, sell-side analysts forecast that ValiRx plc will post -1.74 EPS for the current fiscal year.
About ValiRx
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Read More
- Five stocks we like better than ValiRx
- Amazon’s Record Margins Couldn’t Stop the Sell-Off—Here’s Why
- DoorDash’s $17 Billion Bet on Instacart Faces a Long Regulatory Road Ahead
- FTC Puts A Wrinkle In the Cintas and UniFirst Merger
- Breaching the Valuation: The Real Reason Fortinet Dropped
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.
